Literature DB >> 10822424

"The scarlet E": the presentation of epilepsy in the English language print media.

G L Krauss1, S Gondek, A Krumholz, S Paul, F Shen.   

Abstract

OBJECTIVE: To examine the coverage of epilepsy in English language newspapers and magazines to determine how they portray the medical risks associated with epilepsy, whether they report research and treatment advances accurately, whether stigmatizing biases toward persons with epilepsy persist, and to examine the sources of errors in reporting about epilepsy.
BACKGROUND: The print media reflect and shape current views about epilepsy and other neurologic conditions. They also have the potential to further misconceptions about neurologic issues and particular brain disorders. Persistent myths about epilepsy, such as the ancient belief that it is a demonic disorder, can result in discrimination, emotional difficulties, and reluctance to seek effective treatment.
METHODS: A large commercial database was used to search for stories about epilepsy from approximately 2,000 English language newspapers and popular magazines. Two epileptologists independently classified story themes and main sources, and screened for the presence of gross errors in 210 stories about epilepsy or seizures. The authors analyzed the metaphors and terminology used to describe seizures and epilepsy.
RESULTS: The majority of English language print stories about epilepsy were accurate depictions of social and medical issues regarding the disorder, most commonly depictions of persons overcoming epilepsy and announcements of new therapies and reports of scientific advances. Thirty-one percent of the stories, however, contained gross errors, most commonly scientific inaccuracy, exaggerated treatment claims, and overestimates of the risks of dying during a seizure. New drug therapies were often described inaccurately by physicians and pharmaceutical spokespersons as curative and without side effects. Patients and their families frequently overemphasized the risk of dying during a seizure and misstated medical issues. Most celebrities with recurring seizures denied having epilepsy. Seizures were described with demonic imagery in 6% of stories. United States epilepsy associations discourage labeling patients as "epileptics"; however, the term was used in 45% of stories.
CONCLUSION: Physicians and reporters should be aware of both professional and popular biases that influence the print media's presentation of the causes and consequences of epilepsy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10822424     DOI: 10.1212/wnl.54.10.1894

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

Review 1.  Ethical, legal, and social dimensions of epilepsy genetics.

Authors:  Sara Shostak; Ruth Ottman
Journal:  Epilepsia       Date:  2006-10       Impact factor: 5.864

2.  What's at stake? Genetic information from the perspective of people with epilepsy and their family members.

Authors:  Sara Shostak; Dana Zarhin; Ruth Ottman
Journal:  Soc Sci Med       Date:  2011-07-23       Impact factor: 4.634

3.  Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy.

Authors:  J Von Oertzen; H Urbach; S Jungbluth; M Kurthen; M Reuber; G Fernández; C E Elger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

4.  Stigmatization of repetitive hand use in newspaper reports of hand illness.

Authors:  Shawn Anthony; Santiago Lozano-Calderon; David Ring
Journal:  Hand (N Y)       Date:  2007-05-25

5.  Rheumatoid Arthritis Portrayal by UK National Newspapers 2011-2016: A Service User - Led Thematic Analysis of Language Used.

Authors:  Andrew Mark Bassett; Savia de Souza; Ruth Williams; Heidi Lempp
Journal:  BMC Rheumatol       Date:  2018-02-20

6.  Prediction of seizure recurrence risk following discontinuation of antiepileptic drugs.

Authors:  Margherita Contento; Bruno Bertaccini; Martina Biggi; Matteo Magliani; Ylenia Failli; Eleonora Rosati; Luca Massacesi; Marco Paganini
Journal:  Epilepsia       Date:  2021-07-12       Impact factor: 5.864

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.